数据链接：
官方服务：
资源简介：
G6PD phenotypic characterisation by FST.
应用场景：
创建时间：
2016-03-30
相关数据集
Diagnostic performance of the STANDARD G6PD Test using the manufacturer’s thresholds compared with normalized spectrophotometric reference values, by specimen type.
Diagnostic performance of the STANDARD G6PD Test using the manufacturer’s thresholds compared with normalized spectrophotometric reference values, by specimen type.
NIAID Data Ecosystem60
Evaluation of the CareStart™ glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in the field settings and assessment of perceived risk from primaquine at the community level in Cambodia
Background Primaquine is an approved radical cure treatment for Plasmodium vivax malaria but treatment can result in life-threatening hemolysis if given to a glucose-6-phosphate dehydrogenase deficien
NIAID Data Ecosystem40
Field evaluation of quantitative point of care diagnostics to measure glucose-6-phosphate dehydrogenase activity
Background Glucose-6-Phosphate dehydrogenase (G6PD) deficiency is the most common enzymopathy worldwide, no reliable bedside diagnostic tests to quantify G6PD activity exist. This study evaluated two
NIAID Data Ecosystem20
Performance of the careSTARTTM G6PD biosensor for different residual G-6-PD activity.
Performance of the careSTARTTM G6PD biosensor for different residual G-6-PD activity.
Figshare2019-12-20 更新50
Diagnostic performance of the 6.0 U/g Hb threshold on the STANDARD G6PD Test for females with G6PD deficient and intermediate activity on capillary specimens.
The percent positivity, negativity, and predictive power for all females with > 70%, 65%, and 60% activity are shown. Ninety-five percent confidence intervals are provided in brackets.
NIAID Data Ecosystem30
